COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference

30/11/2017 - 13:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti- [...]

Purepoint Uranium Group Inc. Raises Ceiling for Private Placement

30/11/2017 - 12:45

TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (TSXV:PTU) (the “Company”) announced its intention to raise the ceiling for the previously announced non-brokered private placement (the “Private [...]

ALK secures pricing and reimbursement for ACARIZAX® in France

30/11/2017 - 12:27

Copenhagen, 2017-11-30 12:27 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that it has reached a satisfactory agreement with health authorities in France for the pricing and [...]

Total number of shares and voting rights in Zealand at November 30, 2017

30/11/2017 - 11:13

Company announcement - No. 53 / 2017 Total number of shares and voting rights in Zealand at November 30, 2017 Copenhagen, November 30, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' [...]

About Board Membership of Mr. Salvis Lapins

30/11/2017 - 10:55

Olaine, 2017-11-30 10:55 CET (GLOBE NEWSWIRE) -- AS Olainfarm hereby informs that upon mutual agreement Mr. Salvis Lapins will resign from position of the Board Member by January 12, 2018. Information prepared by: [...]

Top Facial Plastic Surgeon Releases Book for Baby Boomer Women on How to Look Young Again

30/11/2017 - 10:00

NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- According to the American Society of Aesthetic Plastic Surgery, in just the last two decades, the number of cosmetic procedures performed on patients over the age of 65 has [...]

K2M Announces Completion of 300 RHINE™ Cervical Disc System Surgical Cases

30/11/2017 - 10:00

LEESBURG, Va., Nov. 30, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Financial calendar for Zealand Pharma in 2018

30/11/2017 - 09:08

Company announcement - No. 52/2017 Financial calendar for Zealand Pharma in 2018 Copenhagen, November 30, 2017 - Zealand Pharma A/S ("ZEAL") announces the following dates for the company's planned financial reporting in [...]

CORRECTION: Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update

30/11/2017 - 08:14

This is a correction of the announcement from 06:00 30.11.2017 GMT. Reason for the correction: > As of 30 September 2017, Probiodrug held EUR 11.70 million in cash and cash equivalents, providing according to present [...]

Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards

30/11/2017 - 07:56

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards · Dr. Zerhouni credited with transforming Sanofi's R&D into a [...]

Elias Zerhouni, Président Monde de la R&D de Sanofi, nommé « Executive of the Year » aux Scrip Awards

30/11/2017 - 07:56

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Elias Zerhouni, Président Monde de la R&D de Sanofi, nommé « Executive of the Year » aux Scrip Awards Cette distinction reconnaît le rôle joué par le [...]

Novartis' Cosentyx® is first biologic to show long-term efficacy in nail and palmoplantar psoriasis, which can impact up to 90% of psoriasis patients

30/11/2017 - 07:16

Unique Cosentyx ® (secukinumab) data reinforce treatment option for up to 90% of psoriasis patients who may develop nail or palmoplantar psoriasis[1] - [4] Cosentyx results represent the first data on biologic use for [...]

Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update

30/11/2017 - 07:00

HALLE (SAALE), Germany, 30 November 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announces its third quarter [...]

3D Signatures Reports First Quarter Financial Results for Fiscal 2018

30/11/2017 - 01:12

TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based on the three- [...]

Teladoc Announces Pricing of Sale of Shares of Common Stock

30/11/2017 - 00:19

PURCHASE, NY, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) (“Teladoc”) today announced the pricing of the previously announced offering of shares of its common stock, which includes 3,454,000 shares [...]

Dr. Stephen Hudis Sworn in as Vice President of the American College of Prosthodontists

29/11/2017 - 23:32

Chicago, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Stephen I. Hudis, DDS, FACP , was sworn in as Vice President of the American College of Prosthodontists (ACP) during the 47 th Annual Session of the ACP held in San Francisco, [...]

Novartis announces Phase III STRIVE data published in NEJM demonstrating significant and sustained efficacy of erenumab in migraine prevention

29/11/2017 - 23:01

Patients with episodic migraine taking erenumab reported significant and meaningful benefits over six months, with reduced migraine days and acute medication use Fifty percent of patients taking erenumab 140mg had their [...]

Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018

29/11/2017 - 22:30

COPENHAGEN, Denmark, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced the filing of further written submissions in the European Opposition Proceeding for [...]

Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board

29/11/2017 - 22:30

VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob” Dawson to its [...]